Global Health Research Unit on Genomics and enabling data for Surveillance of Antimicrobial Resistance
In plain English
AI plain-English summaryIn Nigeria, India, Colombia, and the Philippines, researchers are embedding whole genome sequencing into national surveillance systems to track how drug-resistant bacteria spread. This project builds a data-driven infrastructure that links local hospitals to national and international decision-makers, turning raw genomic data into actionable reports for infection control. Antimicrobial resistance (AMR) already kills over a million people each year, yet most low- and middle-income countries lack the genomic surveillance needed to spot emerging threats or measure whether interventions work. Without this information, outbreaks go undetected and treatment guidelines remain generic rather than locally relevant. If successful, the unit will deliver a working national surveillance system in Nigeria from scratch, cutting the time needed to implement informed genomic monitoring for AMR. In all four countries, the project will produce routine reports that directly shape hospital infection control policies and national treatment guidelines. The same data architecture will feed into global AMR monitoring networks, helping international bodies track resistance patterns across continents. This is not fundamental science—it is applied infrastructure, designed to make genomic surveillance a routine public health tool rather than a research luxury.
View original technical description
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Original classification
ResearchPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know